- Home
- KTWO vs FDMT Comparison
KTWO vs FDMT Comparison
Compare KTWO & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$9.82
Company Overview
Basic Information| Metric | KTWO | FDMT |
|---|---|---|
| Founded | 2025 | 2013 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 513.6M |
| IPO Year | 2026 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KTWO | FDMT |
|---|---|---|
| Price | $9.87 | $9.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $33.50 |
| AVG Volume (30 Days) | 99.2K | ★ 618.9K |
| Earning Date | N/A | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $85,209,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $9.84 | $2.24 |
| 52 Week High | $9.89 | $12.34 |
Technical Indicators
Market Signals| Indicator | KTWO | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 49.71 | 62.14 |
| Support Level | N/A | $9.85 |
| Resistance Level | $9.89 | $10.48 |
| Average True Range (ATR) | 0.01 | 0.54 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 60.00 | 81.46 |
Price Performance
Historical Comparison KTWO
FDMT
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.